人工智能与大数据在抗感染药物领域中的应用进展

Advances in the application of artificial intelligence and big data in the field of anti-infective drugs

摘要

感染性疾病严重威胁全球公共健康,抗感染药物的研发与质量控制至关重要。近年来,人工智能 (artificial intelligence,AI) 与大数据凭借高效的数据处理能力和模式识别能力,加速药物发现过程,提高药物质量控制水平。本文综述了 AI 与大数据技术在抗感染药物分子筛选、耐药机制研究及广谱候选药物开发中的应用进展,同时总结了其在药品生产与质量控制过程中的关键作用。尽管如此,AI 与大数据技术在抗感染药物研发和质量控制上的应用仍存在不足,未来须通过跨学科融合及提高算法准确性等方法,推动抗感染药物研发和质量控制迈向高效、精准的新阶段。

Abstract

Infectious diseases pose a serious threat to global public health, making the research, development, and quality control of anti-infective drugs of critical importance.In recent years, artificial intelligence (AI) and big data have accelerated the drug discovery process and improved drug quality control levels by leveraging their efficient data processing capabilities and pattern recognition abilities.This article reviews the application of AI and big data in anti-infective drug molecular screening, resistance mechanism research, and broad-spectrum candidate drug development, while also summarizing their key roles in pharmaceutical production and quality control processes. However, the application of AI and big data technology in the development and quality control of anti-infective drugs still has limitations.In the future, it is necessary to promote the integration of interdisciplinary approaches and improve algorithm accuracy to drive the development and quality control of anti-infective drugs toward a new phase of efficiency and precision.

关键词

人工智能 / 大数据 / 抗感染药物 / 药物研发 / 质量控制

Key words

artificial intelligence / big data / anti-infective drugs / drug development / quality control

[1] 缪晓辉. 抗感染药物研究新进展与临床应用[J].药学进展, 2021,45 (6):401-402.
[2] 张健,徐海华.抗生素类药物临床应用现状及作用机制分析[J].中国药物滥用防治杂志,2023,29 (6):999-1001, 1011.
[3] 宋建,都鹏飞.抗病毒药物作用机制的研究进展[J].医学综述,2013,19 (21):3971-3973.
[4] 刘锦燕,郑或鸣,项明洁.新型抗真菌药物研发进展及其作用靶点机制[J].中国感染与化疗杂志,2023,23 (1):121-125.
[5] 胡慧玲. 抗寄生虫药物的作用机制及对机体的不良反应[J].养殖技术顾问,2010 (8):93.
[6] 艾凤庭,刘艳春. β-内酰胺类抗生素在儿童呼吸道感染性疾病治疗中的应用价值分析[J].系统医学,2024,9 (17): 137-140.
[7] 李媛媛. 喹诺酮类抗生素治疗老年感染性疾病的临床药学研究[J].黑龙江医药,2024,37 (3):574-577.
[8] 汤雨晴,郑维义.抗疟疾药物的研究现状与发展[J].中国新药杂志,2019,28 (8):961-966.
[9] MÄSER P,BERNHARD S,BRUN R,et al.Key contributions by the Swiss tropical and public health institute towards new and better drugs for tropical diseases[J].Chimia,2023, 77 (9): 593-602.
[10] World Health Organization.Global antimicrobial resistance and use surveillance system (GLASS) report 2022[M].World Health Organization, 2022.
[11] 胡昌勤. "抗生素药品质量控制与评价专辑":强化市场监管,助力产业发展[J].中国抗生素杂志,2023,48 (3):236-238.
[12] 中共中央,国务院.中共中央国务院印发《质量强国建设纲要》[N].人民日报,2023-02-07 (001).
[13] 胡昌勤. 特邀主编点评:现代药物质量控制与评价[J].中国抗生素杂志,2019,44 (3): 27.
[14] LIN K,YANG Y,CHENG F.A Molecular Image-based Ex-plainable Artificial Intelligence Framework Identifies Novel Can-didate Antibiotics[EB/OL].(2024-07-09)[2024-12-01].https://doi.org/10.1101/2024.07.08.602516.
[15] CESARO A,BAGHERI M,TORRES M,et al.Deep learning tools to accelerate antibiotic discovery[J].Expert Opin Drug Dis-cov,2023,18 (11):1245-1257.
[16] CHOO HY,WEE J,SHEN C,et al.Fingerprint-enhanced graph attention network (FinGAT) model for antibiotic discovery[J].J Chem Inf Model,2023,63 (10):2928-2935.
[17] TORRES MDT,ZENG YM,WAN FP,et al.A generative artifi-cial intelligence approach for antibiotic optimization[EB/OL].(2024-11-28).https://doi.org/10.1101/2024.11.27.625757.
[18] MA Y,GUO ZY,XIA BB,et al.Identification of antimicrobial peptides from the human gut microbiome using deep learning[J]. Nat Biotechnol,2022,40 (6):921-931.
[19] BILAL H,KHAN MN,KHAN S,et al.The role of artificial in-telligence and machine learning in predicting and combating anti-microbial resistance[J].Comput Struct Biotechnol J,2025,27: 423-439.
[20] NAYAK DSK,MAHAPATRA S,ROUTRAY SP,et al.aiGeneR 1.0:an artificial intelligence technique for the revelation of in-formative and antibiotic resistant genes in Escherichia coli[J]. Front Biosci,2024,29 (2): 82.
[21] HUANG DC,YANG MX,ZHENG WX.Integrating AI and deep learning for efficient drug discovery and target identification[J]. J AI Powered Med Innov,2024,2 (1):44-63.
[22] PANG YX,YAO LT,JHONG JH,et al.AVPIden:a new scheme for identification and functional prediction of antiviral peptides based on machine learning approaches[J].Brief Bioin-form,2021,22 (6):bbab263.
[23] MSWAHILI ME,NDOMBA GE,KIM YJ,et al.Relational graph convolution network with multi features for anti-COVID-19 drugs discovery using 3CLpro potential target[J].Curr Bioin-form,2025,20 (1):18-30.
[24] TIMMONS PB,HEWAGE CM.ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides[J].Brief Bioinform, 2021,22 (6):bbab258.
[25] NOVIANDY TR,MAULANA A,IDROES GM,et al.Machine learning for antiviral drug discovery:application of XGBoost-TPE for predicting bioactivity of hepatitis C inhibitors[C]// 2024 In-ternational Conference on Electrical Engineering and Informatics (ICELTICs).2024:62-67.
[26] 梁积浩. 利用机器学习发掘新型抗病毒活性化合物[D].昆明:昆明理工大学,2023.
[27] JIN WG,STOKES JM,EASTMAN RT,et al.Deep learning i-dentifies synergistic drug combinations for treating COVID-19[J].Proc Natl Acad Sci USA,2021,118 (39):e2105070118.
[28] MUELLER SW,KEDZIOR SK,MILLER MA,et al.An over-view of current and emerging antifungal pharmacotherapy for inva-sive fungal infections[J].Expert Opin Pharmacother,2021, 22 (10):1355-1371.
[29] SINGH V,SHRIVASTAVA S,KUMAR SINGH S,et al.Accel-erating the discovery of antifungal peptides using deep temporal convolutional networks[J].Brief Bioinform,2022, 23 (2): bbac008.
[30] ZHANG J,YANG LB,TIAN ZQ,et al.Large-scale screening of antifungal peptides based on quantitative structure-activity rela-tionship[J].ACS Med Chem Lett,2021,13 (1):99-104.
[31] AHMAD A,AKBAR S,TAHIR M,et al.iAFPs-EnC-GA:I-dentifying antifungal peptides using sequential and evolutionary descriptors based multi-information fusion and ensemble learning approach[J].Chemom Intell Lab Syst,2022,222: 104516.
[32] SHARMA R,SHRIVASTAVA S,KUMAR SINGH S,et al. Deep-AFPpred:identifying novel antifungal peptides using pre-trained embeddings from seq2vec with 1DCNN-BiLSTM[J]. Brief Bioinform, 2022, 23 (1):bbab422.
[33] KARADZAS MT,MICHEL AH,MOSBACH A,et al.SATAY-based chemogenomic screening uncovers antifungal resistance mechanisms and key determinants of ATI-2307 and chitosan sen-sitivity[EB/OL].(2024-09-20).https://doi.org/10.1101/2024.09.20.614104.
[34] SHAO YK,SHAO J,DE HOOG S,et al.Emerging antifungal resistance in Trichophyton mentagrophytes:insights from suscep-tibility profiling and genetic mutation analysis[J].Emerg Mi-crobes Infect,2025,14 (1): 2450026.
[35] KWOFIE SK,AGYENKWA-MAWULI K,BRONI E,et al.Pre-diction of antischistosomal small molecules using machine learning in the era of big data[J].Mol Divers,2022, 26 (3): 1597-1607.
[36] HARIGUA-SOUIAI E,OUALHA R,SOUIAI O,et al.Applied machine learning toward drug discovery enhancement:leishmani-ases as a case study[J].Bioinform Biol Insights,2022,16: 11779322221090349.
[37] ZHANG HR,GUO JT,LI HY,et al.Machine learning for arte-misinin resistance in malaria treatment across in vivo-in vitro plat-forms[J].iScience,2022,25 (3): 103910.
[38] KESHAVARZI ARSHADI A,SALEM M,COLLINS J,et al.DeepMalaria:artificial intelligence driven discovery of potent an-tiplasmodials[J].Front Pharmacol,2020,10: 1526.
[39] BORBA JVB,SALAZAR-ALVAREZ LC,FERREIRA LT,et al. Innovative multistage ML-QSAR models for malaria:from data to discovery[J].ACS Med Chem Lett,2024, 15 (8): 1386-1395.
[40] LINCIANO P,QUOTADAMO A,LUCIANI R,et al.High-throughput phenotypic screening and machine learning methods enabled the selection of broad-spectrum low-toxicity antitrypano-somatidic agents[J].J Med Chem,2023,66 (22): 15230-15255.
[41] ICH.Q13 Continuous Manufacturing of Drug Substances and Drug Products[S]. 2022.
[42] 赵瑜,邵学广,尹利辉.化学计量学指导原则在我国制药行业中的需求分析[J].中国药品标准,2024,25 (1):5-9.
[43] 刘露霞,肖金发.机器视觉与深度学习在药品质量控制中的研究进展[J].大众标准化,2025 (8):21-23.
[44] 邹文博,周桂勤,罗苏秦,等.过程分析技术在制药连续制造的质量控制策略[J].中国新药杂志,2021,30 (10):937-946.
[45] 易夏,冯艳春,胡昌勤,等.近红外光谱法探索在线监测注射用五水头孢唑林钠干燥过程中的水分含量[J].沈阳药科大学学报,2017,34 (7):558-564, 574.
[46] 黄磊,韩明芬.智能制造技术在青霉素类药物生产车间的应用探索[J].张江科技评论,2025 (2):99-101.
[47] FAZEKAS B,PÉTERFI O,GALATA DL,et al.Process analyti-cal technology based quality assurance of API concentration and fiber diameter of electrospun amorphous solid dispersions[J]. Eur J Pharm Biopharm,2024,204: 114529.
[48] 王小亮,张秉华,邓玉龙,等.诺氟沙星胶囊近红外在线质量控制初探[J].中国药业,2022,31 (14):83-88.
[49] 戚淑叶,黄伟明,王德刚,等.阿莫西林胶囊生产过程质量控制方案初探[J].中国抗生素杂志,2022,47 (6):575-580.
[50] 赵瑜,朱俐,尹利辉.近红外光谱法分析头孢拉定颗粒的关键质量属性及对其量值的测定50] 赵瑜,朱俐,尹利辉.近红外光谱法分析头孢拉定颗粒的关键质量属性及对其量值的测定[J].中国抗生素杂志,2022,47 (2):203-209.
[51] LÊ LMM,EVELEIGH L,HASNAOUI I,et al.Rapid discrimi-nation and determination of antibiotics drugs in plastic syringes u-sing near infrared spectroscopy with chemometric analysis:Appli-cation to amoxicillin and penicillin[J].J Pharm Biomed Anal, 2017,138:249-255.
[52] VASCONCELOS DE ANDRADE EW,DE LELIS MEDEIROS DE MORAIS C,LOPES DA COSTA FS,et al.A multivariate control chart approach for calibration transfer between NIR spectrometers for simultaneous determination of rifampicin and isoniazid in pharmaceutical formulation[J].Curr Anal Chem,2018,14 (5): 488-494.
[53] 秦晓东,朱俐,赵瑜,等.近红外光谱法快速分析注射用头孢硫脒[J].中国药师,2020,23 (10):2052-2056.
[54] TRENFIELD SJ,JANUSKAITE P,GOYANES A,et al.Predic-tion of solid-state form of SLS 3D printed medicines using NIR and Raman spectroscopy[J].Pharmaceutics,2022,14 (3): 589.
[55] CHONG XM,ZOU WB,YAO SC,et al.Rapid analysis of the quality of amoxicillin and clavulanate potassium tablets using dif-fuse reflectance near-infrared spectroscopy[J].AAPS Pharm Sci Tech,2017,18 (4):1311-1317.
[56] NAGUIB IA,ABDELALEEM EA,HASSAN ES,et al.Partial least squares and linear support vector regression chemometric models for analysis of Norfloxacin and Tinidazole with Tinidazole impurity[J].Spectrochim Acta A Mol Biomol Spectrosc,2020, 239: 118513.
[57] 赵瑜,王晨,胡昌勤,等.基于大数据分析技术的工艺杂质与降解杂质关系的分析方法:CN119811549B[P].2025-08-01.
[58] 赵瑜,秦晓东,朱俐,等.注射用头孢硫脒多晶型表征方法的研究[J].中国抗生素杂志,2020,45 (3):286-292.
[59] 赵瑜,胡昌勤,孙会敏,等.混晶类多晶型药物的表观晶型与杂质形成相关关系分析方法:中国,CN119780366B[P].2025-07-18.
[60] European Medicines Agency (EMA).Guideline on setting speci-fications for related impurities in antibiotics[EB/OL].(2012-06-30)[2025-08-13].https://www.ema.europa.eu/en/documents/scientific-guideline/adopted-guideline-setting-specifi-cations-related-impurities-antibiotics_en.pdf.
[61] 国家药品监督管理局药品审评中心.发酵或半合成化学仿制药抗生素有关物质限度制定指导原则[EB/OL].(2025-07-30)[2025-08-13].https://www.cde.org.cn/main/news/viewInfoCommon/bec0e0dcee2419aca4c59c79063ffcb8.
[62] 王琰,张培培,赵瑜.基于加权 KNN 的高通量红外光谱法溯源分析青霉素 G 酰基转移酶菌属分类[J].光谱学与光谱分析,2025,45 (4):1008-1014.
[63] FU LX,JIA GS,LIU ZM,et al.The applications and advances of artificial intelligence in drug regulation:a global perspective[J].Acta Pharm Sin B,2025,15 (1):1-14.
[64] U.S.Food and Drug Administration.Artificial intelligence in drug manufacturing[EB/OL].(2023-03-02)[2024-07-15].https://www.fda.gov/media/165743/download.
[65] 国家药品监督管理局综合司.人工智能在药品监管领域典型应用场景名单[EB/OL].(2024-06-13)[2024-07-15].https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20240613143003179.html.
[66] AFNAN AA.PAT-A Framework for Innovative Pharmaceutical Development,Manufacturing,and Quality Assurance[D].Den-mark:University of Southern Denmark, 2004.
[67] BERRIDGE JC.ICH Q8:Pharmaceutical development[C]//Pharmaceutical Quality Forum.Arlington:CASSS,2004:1-22.
[68] BORMAN P,HAMILTON P,DIERICK JF.ICH Q14 analytical procedure development[M]//ERMER J,MCB,MILLER JH. Method validation in pharmaceutical analysis:a guide to best practice.2nd ed.Weinheim:Wiley-VCH,2025:217-235.
[69] 陈思,许真玉,石靖.美国FDA 现代化仿制药质量评价系统KASA 介绍[J].药物评价研究,2023,46 (10):2071-2075.
[70] 尚博扬,石思佳,翟宇,等.近红外光谱法对阿苯达唑片进行一致性评价的研究[J].宁夏医学杂志,2019,41 (8):730-732.
[71] 陈春晓,吴宏伟.注射用美洛西林钠舒巴坦钠近红外一致性检验模型的建立[J].海峡药学,2021,33 (5):63-64.
[72] ZHAO Y,HU CQ,YAO SC,et al.A strategy for population pharmaceutical quality assessment based on quality by design[J].J Pharm Anal,2021,11 (5):588-595.
[73] 赵瑜,胡昌勤,姚尚辰,等.一种仿制药品的工艺评价方法和系统:中国,CN110147939B[P].2022-04-08.
[74] 赵瑜,天津九光科技发展有限责任公司.药品质量大数据评价系统 (DQBES)[Z]. 2020.
[75] 赵瑜,李悝,胡昌勤,等.应用于云平台的药品评价系统及方法:中国,CN113705942B[P].2024-05-21.
[76] 赵瑜,王琰,胡昌勤,等.基于严重不良反应数据的药品关键质量属性筛选方法:中国,CN119811696B[P].2025-10-31.
[77] 郑安兵,杨辉华,潘细朋,等.基于近红外光谱和变分自编码建模鉴别多类药物 (英文)[J].光谱学与光谱分析,2020, 40 (12):3946-3952.
[78] 张钦燕. 表面增强拉曼光谱结合化学计量学方法用于三种核苷类抗病毒药物的快速定量分析研究[D].成都:四川大学,2021.
[79] 路皓翔,张静,李灵巧,等.最小角回归结合竞争性自适应重加权采样的近红外光谱波长选择[J].光谱学与光谱分析,2021,41 (6):1782-1788.
[80] YABRÉ M,FEREY L,SAKIRA AK,et al.Green analytical methods of antimalarial artemether-lumefantrine analysis for falsi-fication detection using a low-cost handled NIR spectrometer with DD-SIMCA and drug quantification by HPLC[J].Molecules, 2020,25 (15): 3397.
[81] 李灵巧,李彦晖,殷琳琳,等.基于DCGAN 的拉曼光谱样本扩充及应用研究[J].光谱学与光谱分析,2021,41 (2): 400-407.
[82] LIANG LK,HU JF,SUN G,et al.Artificial intelligence-based pharmacovigilance in the setting of limited resources[J].Drug Saf,2022,45 (5):511-519.
[83] KUSH RD,WARZEL D,KUSH MA,et al.FAIR data sharing: The roles of common data elements and harmonization[J].J Bi-omed Inform,2020,107: 103421.
[84] AL MESLAMANI AZ,SOBRINO I,DE LA FUENTE J.Machine learning in infectious diseases:potential applications and limita-tions[J].Ann Med,2024,56 (1): 2362869.
[85] 省盼盼,罗苏秦,尹利辉.过程分析技术在药品生产过程中的应用[J].药物分析杂志,2018,38 (5):748-757.

基金资助

盖茨基金会国际专家项目、国家药监局重点实验室课题(2025HYZX03)